ES2120443T3 - Composicion farmaceutica para usar en cirugia intraocular. - Google Patents

Composicion farmaceutica para usar en cirugia intraocular.

Info

Publication number
ES2120443T3
ES2120443T3 ES92908283T ES92908283T ES2120443T3 ES 2120443 T3 ES2120443 T3 ES 2120443T3 ES 92908283 T ES92908283 T ES 92908283T ES 92908283 T ES92908283 T ES 92908283T ES 2120443 T3 ES2120443 T3 ES 2120443T3
Authority
ES
Spain
Prior art keywords
intraocular
pharmaceutical composition
intraocular surgery
surgery
urokinase
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES92908283T
Other languages
English (en)
Inventor
Hiroyuki Shimizu
Takahiro Ogawa
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Senju Pharmaceutical Co Ltd
Original Assignee
Senju Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Senju Pharmaceutical Co Ltd filed Critical Senju Pharmaceutical Co Ltd
Application granted granted Critical
Publication of ES2120443T3 publication Critical patent/ES2120443T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
    • A61K38/49—Urokinase; Tissue plasminogen activator
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Ophthalmology & Optometry (AREA)
  • Biomedical Technology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Inorganic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Prostheses (AREA)

Abstract

UNA MEDICINA PARA OPERACIONES INTRAOCULARES QUE CONTIENE UN AGENTE TROMBOLITICO, TAL COMO UROQUINASA, ASI COMO UN POLIMERO BIOCOMPATIBLE, VISCOELASTICO Y QUE PUEDE PREVENIR DE MANERA EFECTIVA EL AUMENTO DE LA TENSION INTRAOCULAR TRAS VARIAS OPERACIONES INTRAOCULARES TALES COMO UN TRASPLANTE DE LENTES INTRAOCULARES.
ES92908283T 1991-04-22 1992-04-20 Composicion farmaceutica para usar en cirugia intraocular. Expired - Lifetime ES2120443T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP3185948A JPH0640943A (ja) 1991-04-22 1991-04-22 眼内手術用剤

Publications (1)

Publication Number Publication Date
ES2120443T3 true ES2120443T3 (es) 1998-11-01

Family

ID=16179682

Family Applications (1)

Application Number Title Priority Date Filing Date
ES92908283T Expired - Lifetime ES2120443T3 (es) 1991-04-22 1992-04-20 Composicion farmaceutica para usar en cirugia intraocular.

Country Status (9)

Country Link
EP (1) EP0540747B1 (es)
JP (1) JPH0640943A (es)
KR (1) KR930700138A (es)
AT (1) ATE170756T1 (es)
CA (1) CA2085732A1 (es)
DE (1) DE69226926T2 (es)
ES (1) ES2120443T3 (es)
TW (1) TW203555B (es)
WO (1) WO1992018163A1 (es)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19606551C2 (de) * 1996-02-22 2000-06-08 Basotherm Gmbh rt-PA zur Prävention des Nachstars nach Kataraktoperation
JP2001213798A (ja) * 2000-01-27 2001-08-07 Mitsubishi-Tokyo Pharmaceuticals Inc 眼科手術補助剤
TW202206084A (zh) * 2020-04-30 2022-02-16 日商樂敦製藥股份有限公司 眼科組成物

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5455782A (en) * 1977-10-06 1979-05-04 Kowa Co Stable urokinase solution and production thereof
JPS5467089A (en) * 1977-11-07 1979-05-30 Dainippon Pharmaceut Co Ltd Urokinase composition
JPH0236128A (ja) * 1988-07-25 1990-02-06 Kiyoshi Kita 眼内注射剤
JPH02167233A (ja) * 1988-11-10 1990-06-27 Kiyoshi Kita 眼内手術補助剤
JPH02164828A (ja) * 1988-12-19 1990-06-25 Taiho Yakuhin Kogyo Kk 水晶体摘出術後の合併症の治療及び防止剤
JPH03291240A (ja) * 1990-04-09 1991-12-20 Santen Pharmaceut Co Ltd 残留水晶体物質除去補助剤

Also Published As

Publication number Publication date
EP0540747A4 (en) 1993-08-04
KR930700138A (ko) 1993-03-13
EP0540747B1 (en) 1998-09-09
WO1992018163A1 (fr) 1992-10-29
TW203555B (es) 1993-04-11
JPH0640943A (ja) 1994-02-15
DE69226926T2 (de) 1999-04-22
CA2085732A1 (en) 1992-10-23
DE69226926D1 (de) 1998-10-15
EP0540747A1 (en) 1993-05-12
ATE170756T1 (de) 1998-09-15

Similar Documents

Publication Publication Date Title
EP0608052A3 (en) Eye stabilizer for ophthalmic laser surgery.
DE122009000026I1 (de) Als carbohydrase-inhibitoren verwendbare thiophen sulfonamide
ES2092220T3 (es) Elemento tibial para una protesis de sustitucion de la rodilla.
ES2079320B1 (es) Disolucion oftalmica a base de un diclofenaco y tobramicina y sus aplicaciones.
IL130861A0 (en) Methods for closing suturable wounds by use of cyanoacrylate ester compositions comprising an antimicrobial agent
DK1093796T3 (da) Emulsioner, der indeholder mindst et uopløseligt organisk UV-filter og en associativ polymer
NO955029L (no) Intravaginalt avleveringssystem
CA2347707A1 (en) Foldable ophthalmic and otorhinolaryngological device materials
DE69026112D1 (de) Nichtoxidierend wirkende ophthalmische zusammensetzungen und verfahren zu ihrer konservierung und anwendung
DK1920764T4 (da) Fluprostenolisopropylester til anvendelse ved behandling af glaukom og okulær hypertension
ES2071227T3 (es) Composicion para gotas para los ojos.
MX9203243A (es) Oxazolidinonas y composiciones farmaceuticas que las contienen.
NZ237309A (en) 1-(2-(4-morpholino)ethyl)-3-(arylcarbonyl)-indole derivatives and pharmaceutical compositions
ES2120443T3 (es) Composicion farmaceutica para usar en cirugia intraocular.
BR9812166A (pt) Lente intra-ocular
DE69413090D1 (de) Verwendung von 5-Amino-Phthaloylhydrazid als antihypoxisches und defensives Mittel
ES2078175B1 (es) Formulacion farmaceutica conteniendo clobetasona y tobramicina y sus aplicaciones.
DK0552205T3 (da) Ny medicinsk anvendelse af et vist indolderivat og farmaceutisk præparat indeholdende dette
FR2702955B1 (fr) Instrument pour chirurgie oculaire.
DE69100171D1 (de) Synergistische kombination zur ophthalmischen verwendung.
ATE342701T1 (de) Intraocularlinse
ATE78463T1 (de) Schwefelhaltige acrylsaeureester und diese enthaltende fungizide.
ES2121861T3 (es) Antihelminticos de bencimidazol.
DE69614577D1 (de) Polyamin-antagonisten enthaltende intraokulare irrigationslösung
AR020081A1 (es) Nuevo uso

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 540747

Country of ref document: ES